Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of poly-γ-glutamic acid-crosslinked-pectin-based nanogel and its antioxidant and antibacterial properties.

World journal of microbiology & biotechnology·2026
Same author

Jejunal Mesenteric Well-Differentiated Liposarcoma With Isolated Omental Metastases: Evidence of Focal Dedifferentiation.

Cureus·2026
Same author

Is chemical asymmetry necessary for directed motion in catalytic swimmers?

The Journal of chemical physics·2026
Same author

Comparative Analysis of Traditional and Vaginoscopic Approach in Patients Undergoing Diagnostic Hysteroscopy.

Journal of obstetrics and gynaecology of India·2026
Same author

Missed Opportunities in Tuberculosis (TB) Prevention in Pediatric Population: A Retrospective Observational Study From North India.

Cureus·2026
Same author

Neutrophil extracellular traps in rheumatoid arthritis: biomarkers, drivers, and emerging therapeutic targets.

Clinical and experimental immunology·2026

Related Experiment Video

Updated: Jun 5, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

10.8K

Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy.

Sangeeta Kumari1, Shraddha Gupta1, Aisha Jamil1

  • 1Fels Cancer Institute for Personalized Medicine and Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.

Journal of Cellular Physiology
|December 16, 2024
PubMed
Summary

Epithelial ovarian cancer (EOC) cells reprogram metabolism to fuel growth and resistance. Targeting these metabolic vulnerabilities offers new therapeutic strategies for this aggressive cancer.

More Related Videos

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.5K
Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.5K

Related Experiment Videos

Last Updated: Jun 5, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

10.8K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.5K
Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.5K

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Reproductive System Malignancies

Background:

  • Epithelial ovarian cancer (EOC) exhibits high mortality and low survival rates due to aggressive tumor behavior, late diagnosis, and metabolic reprogramming.
  • EOC cells adapt by altering carbohydrate, lipid, and amino acid metabolism to support proliferation, metastasis, and treatment resistance.

Purpose of the Study:

  • To review metabolic targets for epithelial ovarian cancer treatment.
  • To provide an overview of current clinical trials investigating ovarian cancer metabolism.

Main Methods:

  • Literature review of preclinical and clinical studies on EOC metabolism.
  • Analysis of metabolic reprogramming in EOC cells.
  • Summary of therapeutic strategies targeting metabolic vulnerabilities.

Main Results:

  • Metabolic reprogramming is crucial for EOC growth, metastasis, chemotherapy resistance, and immune evasion.
  • Targeting metabolic pathways shows promise in preclinical settings, with some therapies in clinical trials.
  • Challenges include tumor heterogeneity, adaptive resistance, and the tumor microenvironment.

Conclusions:

  • Metabolism-based therapies hold significant potential for transforming EOC treatment.
  • Future research should focus on combination therapies (metabolic inhibitors with immunotherapy/chemotherapy).
  • Precision medicine and multi-omics approaches are vital for personalized treatment strategies.